Dr. Elizabeth C. Dees, MD

Dr. Dees practices at UNC Hospitals in Chapel Hill, North Carolina, part of University of North Carolina Health Care System.

Dr. Dees' NPI, 1578631644, was assigned on November 30, 2006. Dr. Dees graduated from Duke University School of Medicine in 1993.

Dr. Dees' primary practice is UNC Hospitals, at 101 Manning Drive, Chapel Hill, NC 27514 in Orange County. The practice phone is (919) 966-4141.

Dr. Dees' primary practice is UNC Hospitals in Chapel Hill, North Carolina, part of University of North Carolina Health Care System. The medical group on file is UNC Faculty Physicians. Dmand AI also links Dr. Dees to 1 more therapy and rehab clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dees practices, 2 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Dees' primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Dees has a license on file in North Carolina.

CMS data shows 331 Medicare services from Dr. Dees across 4 procedure codes in 2024, for 123 Medicare patients. Medicare paid $17,009 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 123 Medicare patients who saw Dr. Dees in 2024. The largest group is 65 to 74, with 64 patients. 75% of them have cancer, and 63% have high blood pressure. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dees' median patient age at 73, with 97% women.

In 2024, Dr. Dees wrote 745 Medicare Part D claims for 141 patients. 90% of them were for generic drugs. CMS names the drug for 625 of them, across 11 drugs with 11 or more claims each, at $491,227 in total drug cost. In 2023, CMS named 650 claims across 10 drugs.

Dr. Dees accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dees as offering telehealth.

Dmand AI links 62 papers to Dr. Dees, published from 2008 to 2025. 2017 was the busiest year, with 6. The most frequent topics are Breast Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Antineoplastic Agents. Dr. Dees has published most often in Breast Cancer Res Treat. Dr. Dees' most frequent co-authors are Carey Kernodle Anders, MD, Trevor Augustus Jolly, MD and Robert Gray, MD.

Dmand AI links Dr. Dees to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Breast Neoplasms, Triple Negative Breast Neoplasms and Neoplasm Metastasis. National Cancer Institute (NCI) sponsors the most, 5.

CMS Open Payments shows 13 general payments to Dr. Dees from 3 drug and device companies from 2016 to 2022. Consulting fees make up the largest share, 66% of the total. Sanofi and Genzyme US Companies paid the most, $13,808. It also lists 2 research payments totaling $1,270 in 2020.

Dr. Dees graduated from Duke University School of Medicine in 1993.